USA Lab Tested
Fast Shipping
Volume Discounts
Dedicated Support
Affordable Quality
Purity Guaranteed

CJC-1295 (no DAC) + Ipamorelin [5mg/5mg]

CJC-1295 is a growth-hormone–releasing hormone (GHRH) analogue that supports the natural release of growth hormone by interacting with and stimulating the GHRH receptor. Research models have examined its ability to extend the activity of endogenous GHRH signaling and influence downstream GH/IGF-1 pathways.

Ipamorelin is among the most selective growth-hormone secretagogues studied to date and functions as a potent agonist of the ghrelin/GHSR (growth hormone secretagogue receptor). It has been investigated across multiple experimental settings for its effects on GH secretion and its potential influence on bone metabolism, tissue repair, gastrointestinal motility, and pancreatic signaling.

When CJC-1295 and Ipamorelin are evaluated together, research has reported synergistic effects on GH secretion due to their complementary mechanisms—CJC-1295 acting through the GHRH receptor pathway and Ipamorelin acting through the ghrelin receptor pathway. This dual-pathway interaction is of interest in studies examining coordinated growth hormone modulation.

Original price was: $125.00.Current price is: $79.99.

CJC-1295 (no DAC) + Ipamorelin [5mg/5mg]

CJC-1295 is a growth-hormone–releasing hormone (GHRH) analogue that supports the natural release of growth hormone by interacting with and stimulating the GHRH receptor. Research models have examined its ability to extend the activity of endogenous GHRH signaling and influence downstream GH/IGF-1 pathways.

Ipamorelin is among the most selective growth-hormone secretagogues studied to date and functions as a potent agonist of the ghrelin/GHSR (growth hormone secretagogue receptor). It has been investigated across multiple experimental settings for its effects on GH secretion and its potential influence on bone metabolism, tissue repair, gastrointestinal motility, and pancreatic signaling.

When CJC-1295 and Ipamorelin are evaluated together, research has reported synergistic effects on GH secretion due to their complementary mechanisms—CJC-1295 acting through the GHRH receptor pathway and Ipamorelin acting through the ghrelin receptor pathway. This dual-pathway interaction is of interest in studies examining coordinated growth hormone modulation.

Original price was: $125.00.Current price is: $79.99.

Product Usage: For Research Use Only – Not for Human or Veterinary Use

This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the FDA. It is strictly intended for in vitro research by qualified professionals. Any use in humans or animals is strictly prohibited and may violate federal, state, or local laws, including the Federal Food, Drug, and Cosmetic Act. No therapeutic or diagnostic application is implied or permitted. The purchaser assumes all responsibility for compliance with applicable regulations.

Product Name:

CJC-1295 (without DAC) / Ipamorelin – Peptide Blend

Chemical Information:

  • CJC-1295 (without DAC)
    • Molecular Formula: C152H252N44O42
    • Molecular Weight: 3647 Da
    • Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gly-Gly-Gly
    • Structure Class: Long-acting GHRH analog (includes Drug Affinity Complex)
  • Ipamorelin
    • Molecular Formula: C38H49N9O5
    • Molecular Weight: 711.85 Da
    • Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
    • Structure Class: Selective Ghrelin Receptor Agonist

Description

This research formulation combines CJC-1295 (with DAC), a long-acting growth hormone–releasing hormone (GHRH) analog, with Ipamorelin, a selective ghrelin (GHSR) receptor agonist. The combination is studied in controlled laboratory environments to evaluate their complementary interactions within growth hormone signaling pathways.

CJC-1295 (DAC) is characterized by its extended activity profile through reversible binding to serum albumin, allowing for prolonged stimulation of endogenous growth hormone release. Ipamorelin is investigated for its role in initiating rapid, pulsatile GH secretion via ghrelin receptor activation. Together, this blend is used in in vitro research models to explore hormone regulation dynamics, anabolic signaling, and cellular recovery mechanisms.

The product is supplied as a sterile, lyophilized powder and is intended exclusively for laboratory research applications.

Research Applications

CJC-1295 (DAC) / Ipamorelin is being studied in research settings for its potential to:

  • Evaluate endogenous GH secretion patterns, including sustained and pulsatile release dynamics

  • Investigate anabolic signaling pathways, with relevance to protein synthesis and cellular growth

  • Examine recovery and regenerative mechanisms, including tissue repair and cellular turnover

  • Explore metabolic and circadian influences, particularly as they relate to growth hormone rhythms

Storage & Handling

  • Store lyophilized powder at -20°C

  • After reconstitution, store at 2–8°C and use within a short timeframe

  • Employ proper aseptic technique during handling to maintain sample integrity

Product Specifications

  • Purity: ≥99% (HPLC-verified)

  • Form: Lyophilized white powder

  • Solubility: Soluble in bacteriostatic water

Compliance Notice

This product is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the U.S. Food and Drug Administration (FDA). Any use outside of legitimate in vitro research is strictly prohibited and may violate applicable laws. By purchasing this product, the buyer represents and warrants that it will be used solely for lawful research purposes.

Related Products

Shopping Cart
cjc 1295 without dac + ipamorelin [5mg/5mg]CJC-1295 (no DAC) + Ipamorelin [5mg/5mg]
Original price was: $125.00.Current price is: $79.99.